Chesire, United Kingdom

Michael Wardleworth


Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Chesire, GB (2004 - 2007)
  • Macclesfield, GB (2008)

Company Filing History:


Years Active: 2004-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michael Wardleworth: Innovator in Pharmaceutical Chemistry

Introduction

Michael Wardleworth is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as gonadotropin-releasing hormone (GnRH) antagonists. With a total of three patents to his name, Wardleworth's work has implications for therapeutic treatments in various medical conditions.

Latest Patents

Wardleworth's latest patents include innovative compounds that have the potential to revolutionize treatment options. One of his notable inventions is the "Indolylalkylamino-methylidenecarbamate derivatives useful as GnRH antagonists." This invention relates to a group of novel indole compounds that are effective as GnRH antagonists. The patent also covers pharmaceutical formulations of these compounds, methods of treatment using them, and processes for their preparation. Another significant patent is for "3-aminoalkyl-2-aryl-indole derivatives and their use as GnRH antagonists." This invention focuses on compounds that act as antagonists of GnRH activity, along with their pharmaceutical formulations and therapeutic applications.

Career Highlights

Michael Wardleworth is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to the development of innovative treatments that address critical health issues. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Wardleworth has collaborated with esteemed colleagues, including Alexander Graham Dossetter and Christopher Thomas Halsall. These collaborations have fostered an environment of innovation and have led to the advancement of various pharmaceutical projects.

Conclusion

Michael Wardleworth's contributions to pharmaceutical chemistry, particularly in the area of GnRH antagonists, highlight his role as an influential inventor. His patents and work at AstraZeneca demonstrate his commitment to advancing medical science and improving therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…